CONSULTING AGREEMENT
This CONSULTING AGREEMENT ("Consulting Agreement"), is effective July 16, 1999 by and between
Senesco Technologies, Inc., an Idaho corporation with a place of business at 34 Chambers St., Princeton, NJ
08542 ("SENESCO"), and Alan B. Bennett Ph.D., whose address is Mann Laboratories, University of
California, Davis, CA 95616 ("Bennett"):
WHEREAS, SENESCO is engaged in the business of research and development on plant genes and their
cognate expressed proteins that are induced during or coincident with the onset of senescence, which may initiate
or facilitate senescence of plants or plant tissues, together with methods for controlling senescence that involve
altering the expression of these genes;
WHEREAS, Bennett may possess useful knowledge and technical expertise relating to SENESCO research and
product development;
WHEREAS, SENESCO wishes to retain Bennett for professional consulting services;
WHEREAS, Bennett may receive, disclose, learn or acquire valuable and proprietary technical and commercial
trade secrets and confidential information of SENESCO (collectively, the "Confidential Information"), from
SENESCO or otherwise as a result of performing his consulting services under this Consulting Agreement;
WHEREAS, SENESCO and Bennett wish to assure that such information be held in secrecy and confidence by
Bennett;
NOW, THEREFORE, in consideration of the foregoing and the mutual promises and covenants contained herein,
the parties agree as follows:
I. DEFINITIONS.
"Technology and Inventions" shall mean any and all discoveries, inventions, conceived inventions and know-how,
whether or not patentable, and whether or not reduced to practice, including any and all methods or processes,
test data, findings, designs, machines, devices, apparatus, manufactures, and any improvements and/or any utility
for the foregoing, which are made, conceived, discovered or developed by Bennett, whether alone or in
conjunction with others, which arise in any way from, during or a